Renal dosing and insufficiency: Drug dosing considerations
Dosing
- Usual Dosage: 5 - 10 mg/kg q8h
- CrCl 30 - 49 mL/min: Usual dose q12h
- CrCl 10 - 29 mL/min: Usual dose q24h
- ESRD (CrCl < 10 mL/min): 50% of usual dose q24h
- Monitor for CNS toxicity
- PD: 50% of usual dose q24h
- Monitor for CNS toxicity
- HD: 50% of usual dose q24h
- On dialysis days, give daily dose towards the end of HD
- Monitor for CNS toxicity
- CRRT: Usual dose q12h
Administration: To reduce the risk of crystalline nephropathy, infuse 500 mL normal saline before starting acyclovir infusion. Infuse NS at 100 mL/h for a total infusion time of 5 hours.
*Restricted to Critical Care Medicine, Infectious Diseases and Neurology/Neurosurgery for herpes encephalitis
Dosing
- Usual Dosage: Variable
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: 800 mg q8h. Max 2400 mg per day.
- ESRD (CrCl < 10 mL/min): 800 mg q12h. Max 1600 mg per day.
- Monitor for CNS toxicity
- PD: 800 mg q12h. Max 1600 mg per day.
- Monitor for CNS toxicity
- HD: 800 mg q12h. Max 1600 mg per day.
- On dialysis days, give one of the doses after HD
- Monitor for CNS toxicity
- CRRT: Usually IV acyclovir is used
Dosing
- Usual Dosage: 100 mg q12h
- CrCl 60 - 79 mL/min: 200 mg q2days (i.e., day 1, 3, 5, etc) alternating with 100 mg q2days (i.e., day 2, 4, 6, etc)
- CrCl 40 - 59 mL/min: 100 mg daily
- CrCl 30 - 39 mL/min: 100 mg 4 days per week
- CrCl 20 - 29 mL/min: 100 mg 3 days per week
- CrCl 10 - 19 mL/min: 200 mg q2weeks (i.e., week 1, 3, 5, etc) alternating with 100 mg q2weeks (i.e., week 2, 4, 6, etc)
- ESRD (CrCl < 10 mL/min): 100 mg once weekly
- PD: 100 mg once weekly
- HD: 100 mg once weekly (not significantly dialyzed)
- CRRT: 100 mg q48h
Please refer to the guideline for aminoglycosides.
Dosing
- Usual Dosage: 500 mg q8h
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage
- On dialysis days, give one of the doses towards the end of HD (removed by HD)
- CRRT: Usual dosage
For Gram negative bacteremia in patients with normal renal function, doses of up to 1 g TID may be considered
Dosing
Oral Formulation:
- Dose adjustment not required
IV Formulation:
- > 30 mL/min: No change
- 10-30 mL/min: 500mg/100mg IV every 8 hours
- < 10 mL/min: 500mg/100mg IV every 12 hours
- HD: 500mg/100mg IV every 8 hours (cleared by dialysis)
Dosing
- Usual Dosage: 0.5 to 1 mg/kg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 3 to 5 mg/kg q24h
- No dosage adjustment for renal impairment or dialysis
*Restricted to Infectious Diseases
Dosing
- Usual Dosage: 2 g q4 - 6h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: 2 g IV q6h
- ESRD (CrCl < 10 mL/min): 2 g q8 - 12h
- PD: 2 g q8 - 12h
- HD: 2 g q8 - 12h
- On dialysis days, give one of the doses towards the end of HD (removed by HD)
- CRRT: 2 g q4 - 6h
- SLED: 2 g q4 - 6h on dialysis days; and ESRD dosing on non-dialysis days
Dosing
- Usual Dosage: Variable
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 250 to 500 mg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 70 mg load, then 50 mg q24h
- No dosage adjustment for renal impairment or dialysis
* Restricted to Infectious Diseases
Dosing
- Usual Dosage: 1 to 2 g q8h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: 1 to 2 g q12h
- ESRD (CrCl < 10 mL/min): 1 to 2 g q24h
- PD: 1 to 2 g q24h
- HD: 1 to 2 g 3 days per week towards the end of HD (removed by HD).
- No dose on non-dialysis days.
- CRRT: Usual dosage
- SLED: 1 to 2 g q8h on dialysis days; and ESRD dosing on non-dialysis days
Dosing
- Usual Dosage: 2 g q8h
- CrCl 30 - 49 mL/min: 2 g q8h
- CrCl 10 - 29 mL/min: 2 g q12h
- ESRD (CrCl < 10 mL/min): 2 g q24h
- PD: 2 g q24h
- HD: 2 g q24h or 2 g qHD
- On dialysis days, give dose towards the end of HD (removed by HD).
- CRRT: Usual dosage
- SLED: 2 g q8h on dialysis days; and ESRD dosing on non-dialysis days
Dosing
- Usual Dosage: 1 g q24h (Exceptions: 2 g q12h for meningitis, infective endocarditis, osteomyelitis)
- No dosage adjustment for renal impairment or dialysis
- Note: For ward patients, orders specifying >1 g per day for indications other than those listed above will automatically be converted to 1 g every 24h hours
- Note: For ICU patients with sepsis and CrCl > 60 mL/min, consider increasing ceftriaxone dose to 2 g IV daily
Dosing
- Usual Dosage: 500 mg q12h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage
- On dialysis days, give one of the doses after HD (removed by HD).
- CRRT: Usual dosage
Dosing
- Usual Dosage: 500 mg q6h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage
- On dialysis days, give one of the doses after HD (removed by HD).
- CRRT: Usual dosage
For Gram negative bacteremia in patients with normal renal function, doses of up to 1 g QID may be considered
Dosing
Creatinine Clearance ≥ 30 mL/min
Usual Dose:
- Oral: 500 mg PO q12h
- IV: 400 mg IV q12h
High-Dose Therapy (i.e., for Pseudomonas or bone and joint infections):
- Oral: 750 mg PO q12h
- IV: 400 mg IV q8h
Creatinine Clearance < 30 mL/min
Usual Dose:
- Oral: 500 mg PO q24h
- IV: 400 mg IV q 24h*
*In critical illness use 400mg IV q12h1,2
High-Dose Therapy (i.e., for Pseudomonas or bone and joint infections):
- Oral: 750 mg PO q24h
- IV: 400 mg IV q12h*
*In critical illness use 400mg IV q8h1,2
Automatic Substitution Policy:
- Orders for 200 mg IV q12h will be converted to 400 mg IV q24h
Peritoneal Dialysis (PD)
Usual Dose:
- Oral: 500 mg PO q24h*
- IV: 400 mg IV q24h*
*In peritoneal dialysis related peritonitis higher doses of 500mg PO q12h or 400mg IV q12h can be considered3,4
High-Dose Therapy (i.e., for Pseudomonas or bone and joint infections):
- Oral: 750 mg PO q24h*
- IV: 400 mg IV q12h*
*In peritoneal dialysis related peritonitis higher doses of 750mg PO q12h or 400mg IV q8h should be considered3,4
Hemodialysis (HD)
Usual Dose:
- Oral: 500 mg PO q24h
- IV: 400 mg IV q24h
- Schedule without regard to time of HD, since only about 10% is removed with HD
High-Dose Therapy (i.e., for Pseudomonas or bone and joint infections):
- Oral: 750 mg PO q24h
- IV: 400 mg IV 12h
- Schedule without regard to time of HD
Continuous Renal Replacement Therapy (CRRT)
Usual Dose:
- Oral: 500 mg PO q12h
- IV: 400 mg IV q12h
High-Dose Therapy (i.e., for Pseudomonas or bone and joint infections):
- Oral: 750 mg PO q12h
- IV: 400 mg IV q8h
References:
- de Vroom SL, et al. Pharmacokinetic/pharmacodynamic target attainment of ciprofloxacin in adult patients on general wards with adequate and impaired renal function. Int J Antimicrob Agents. 2020 Nov;56(5):106166
- Gieling EM, et al. Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen Susceptibility. Clin Pharmacol Ther. 2020 Oct;108(4):770-774.
- Yeung SM, et al. Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis. Perit Dial Int. 2004 Sep-Oct;24(5):447-53.
- Lee C, et al. Steady-State Pharmacokinetics of Oral Ciprofloxacin in Continuous Cycling Peritoneal Dialysis Patients: Brief Report. Perit Dial Int. 2018 Jan-Feb;38(1):73-76
- Brown P, et al. Principles of Drug Dosing in Sustained Low Efficiency Dialysis (SLED) and Review of Antimicrobial Dosing Literature. Pharmacy (Basel). 2020 Mar 9;8(1):33
Dosing
- Usual Dosage: 500 mg q12h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): 500 mg load, then 250 mg q12h
- PD: 500 mg load, then 250 mg q12h
- HD: 500 mg load, then 250 mg q12h
- CRRT: Usual dosage
Dosing
Usual Dosage:- Intravenous: 600 mg IV q8h*
- Oral: 300 – 450 mg PO q6h
- *Auto-Sub: A dose of 900 mg IV q8h is recommended for: necrotizing fasciitis; cerebral toxoplasmosis; pelvic inflammatory disease; postpartum endometritis; and intrapartum prevention of perinatal group B streptococcal disease in patients who cannot be given penicillin
No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 2 g IV q4 - 6h
- No dosage adjustment for renal impairment or dialysis
Dosing
Loading dose (for all patients): 300 mg IV x1; then followed with maintenance dosing:
Maintenance Dose (for non-dialysis): Dose based on calculated creatinine clearance
| Creatinine Clearance (mL/min) |
Dose Recommendation* |
|---|---|
| 0 | 67.5 mg Q12H |
| 5 to <10 | 75 mg Q12H |
| 10 to <20 | 82.5 mg Q12H |
| 20 to <30 | 90 mg Q12H |
| 30 to <40 | 97.5 mg Q12H |
| 40 to <50 | 112.5 mg Q12H |
| 50 to <60 | 120 mg Q12H |
| 60 to <70 | 135 mg Q12H |
| 70 to <80 | 150 mg Q12H |
| 80 to <90 | 172.5 mg Q12H |
| ≥ 90 | 180 mg Q12H |
*Given normal and expected fluctuations in creatinine during therapy, consider dose adjustments only when there is a clear trend of change in renal function.
Maintenance Dose in Dialysis:
- IHD:
- Non-dialysis days: 67.5 mg IV Q12H
- Dialysis days: 90 mg IV Q12H (one dose given before dialysis, the other following dialysis)
- SLED: dose similarly to iHD (assumes a 3-4 hour session)*
*If SLED is longer than 4 hours, Infectious Diseases/ pharmacy for dosing assistance - CRRT: 217.5 mg IV Q12H
- PD: 82.5 mg IV Q12H
- For the Treatment of Pneumonia
- Consider the addition of inhaled colistimethate 75 mg inhaled BID
References:
- International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Antiinfective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019 Jan;39(1):10-39.
- ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016;36 (5): 481-508
Dosing
- Usual Dosage: Dose varies with indication
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage
- On dialysis days, give dose after HD (removed by HD).
- CRRT: Usual dosage
Dosing
- Round all doses to the nearest 50 mg
-
If CrCL ≥ 30 mL/min:
- Skin and skin structure infections: 4 to 6 mg/kg IV q24h
- Staphylococcus aureus bacteremia: 6 to 10 mg/kg IV q24h*
*Note: Doses as high as 8-12 mg/kg IV q24h have been used for indications such as infective endocarditis, osteomyelitis, prosthetic joint infections and infections caused by VRE
If CrCl < 30 mL/min:
- Same dose q48h
- Hemodialysis: Usual dose IV q48h or 10 mg/kg after every hemodialysis session
- Peritoneal dialysis: same dose q48h
- CRRT: usual dosage
- SLED: q24h post-SLED
Dosing
- Usual Dosage: 100 to 200 mg/day
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 1 g q24h
- CrCl 30 - 49 mL/min: Usual dose
- CrCl 10 - 29 mL/min: 500 mg q24h
- ESRD (CrCl < 10 mL/min): 500 mg q24h
- PD: 500 mg q24h
- HD: 500 mg q24h
- On dialysis days, give dose towards the end of HD.
- CRRT: Usual dose
- SLED: 1 g IV q24h on dialysis days; and ESRD dosing on non-dialysis days
Dosing
- Usual Dosage: 500 mg q6h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage.
- CRRT: Max 2 g/day
Dosing
- Usual Dosage: 15 to 25 mg/kg q24h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dose 3 days per week
- ESRD (CrCl < 10 mL/min): Usual dose 3 days per week
- PD: Usual dose 3 days per week
- HD: Usual dose 3 days per week after HD
- CRRT: 15 mg/kg q24h
Dosing
- Usual Dosage: 200 to 800 mg q24h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dose q48h
- ESRD (CrCl < 10 mL/min): Usual dose q48h
- PD: Usual dose q48h
- HD: Usual dose 3 days per week
- If IV, give towards the end of HD
- If PO, give after HD
- CRRT: 600 mg q24h
* Restricted to Critical Care Medicine and Infectious Diseases
Foscarnet
Dosing
Usual Dosage:
- Induction: 5 mg/kg q12h
- Maintenance: 5 mg/kg q24h
| Induction | Maintenance | |
| CrCl 50 - 69 mL/min: | 2.5 mg/kg q12h | 2.5 mg/kg q24h |
| CrCl 30 - 49 mL/min: | 2.5 mg/kg q24h | 1.25 mg/kg q24h |
| CrCl 10 - 29 mL/min: | 1.25 mg/kg q24h | 0.625 mg/kg q24h |
| ESRD (CrCl < 10 mL/min): | 1.25 mg/kg 3 days per week | 0.625 mg/kg 3 days per week |
| PD: | 1.25 mg/kg 3 days per week | 0.625 mg/kg 3 days per week |
| HD: |
1.25 mg/kg 3 days per week Give dose towards the end of HD. |
0.625 mg/kg 3 days per week Give dose towards the end of HD |
| CRRT: | 2.5 mg/kg q12h |
2.5 mg/kg q24h |
*Restricted to Infectious Diseases
Please refer to the guideline for aminoglycosides.
Dosing
- Usual Dosage: 5 mg/kg q24h. Max 300 mg.
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage
- On dialysis days, give dose after HD.
- CRRT: Usual dosage
Dosing
- Usual Dosage: 100 to 200 mg q12h
- No dosage adjustment for renal impairment or dialysis
* Restricted to Infectious Diseases
Dosing
- Usual Dosage: 750 mg q24h
- CrCl 30 - 49 mL/min: 750 mg load; then 500 mg q24h
- CrCl 10 - 29 mL/min: 750 mg q48h
- ESRD (CrCl < 10 mL/min): 750 mg load, then 500 mg q48h
- PD: 750 mg load, then 500 mg q48h
- HD: 750 mg load, then 500 mg q48h
- Schedule dose without regard to time of HD.
- CRRT: Usual dosing
Dosing
- Usual Dosage: 600 mg q12h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dosage
- PD: Usual dosage
- HD: Usual dosage (see below)
- If IV, on dialysis days, give one of the doses towards the end of HD
- If PO, on dialysis days, give one of the doses after HD.
- CRRT: Usual dosage
- SLED: Usual dosage (see below)
- If IV, on dialysis days, give one of the doses towards the end of SLED
- If PO, on dialysis days, give one of the doses after SLED.
* Restricted to Infectious Diseases
Dosing
Usual Dosage:
- Non-Deep Seated Infection: 500 mg q6h
- Deep Seated Infections (meningitis, endocarditis, or osteomyelitis): 2 g q8h
| Non-Deep Seated Infection | Deep Seated Infection | |
| CrCl 30 - 49 mL/min: | Usual dose | 2 g load; then 500mg q6h |
| CrCl 10 - 29 mL/min: | 500 mg q8h | 2 g load; then 500 mg q6h |
| ESRD (CrCl < 10 mL/min): | 500 mg q12h | 1 g load; then 500 mg q8h |
| PD: | 500 mg q12h | 1 g load; then 500 mg q8h |
| HD: |
500 mg q12h On dialysis days, give one of the doses towards the end of HD. |
1 g load; then 500 mg q8h On dialysis days, give one of the doses towards the end of HD. |
| CRRT: | Usual dose | Usual dose |
| SLED: | Usual dose on dialysis days; and ESRD dosing on non-dialysis days | Usual dose on dialysis days; and ESRD dosing on non-dialysis days |
* Restricted to Critical Care Medicine and Infectious Diseases
Dosing
- Usual Dosage: 500 mg q12h (Exception: 500 mg q8h for C. difficile infection, brain abscess)
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 400 mg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- CrCl < 40 mL/min: Avoid (due to lack of efficacy)
- ESRD (CrCl < 10 mL/min): Avoid
- PD: Avoid
- HD: Avoid
- CRRT: Avoid
Dosing
Usual Dosage:
| Treatment | Prophylaxis | |
| CrCl unknown | 75 mg BID; to be re-assessed when CrCl known | 75 mg now; then 75 mg once daily; to be re-assessed when CrCl known |
| CrCl > 60 mL/min | 75 mg BID | 75 mg now; then 75 mg once daily |
| CrCl 30 - 60 mL/min: | 45 mg BID | 45 mg now; then 45 mg once daily |
| CrCl 10 - 29 mL/min: | 45 mg once daily | 45 mg now; then 45 mg q 2 days |
| ESRD (CrCl < 10 mL/min): | 75 mg now; then one additional 75 mg dose on day 3 | 45 mg now; then 45 mg q 3 days |
| PD: | 75 mg now; then one additional 75 mg dose on day 3 | 45 mg now; then 45 mg q 3 days |
| HD: |
75 mg now; then 75 mg after each of the next 2 HD |
45 mg now; then 45 mg post-HD x 3 doses per week |
| CRRT: | 45 mg BID | 45 mg now; then 45 mg once daily |
Dosing
- Usual Dosage: 2 to 4 MU q4 - 6h (no dosage reduction for oral)
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Max 16 MU/day (e.g., 4 MU q6h)
- ESRD (CrCl < 10 mL/min): Max 12 MU/day (e.g., 4 MU q8h)
- PD: Max 12 MU/day (e.g., 4 MU q8h)
- HD: Max 12 MU/day (e.g., 4 MU q8h)
- On dialysis days, give one of the doses towards the end of IHD.
- CRRT: Usual dosage
Dosing
- Usual Dosage: 4 mg/kg q24h
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dosage
- ESRD (CrCl < 10 mL/min): Usual dose q24 - 36h
- PD: Usual dose q24 - 36h
- HD: Usual dose q24 - 36h
- CRRT: Usual dosage
* Restricted to Infectious Diseases
Dosing
- Usual dosage:3.375 g q6h
- Pseudomonas dosage:4.5 g q6h
Renal Insufficiency:
| CREATININE CLEARANCE (mL/min) | USUAL DOSAGE | PSEUDOMONAS DOSAGE |
|---|---|---|
| 10 to 29 | 3.375 g q8h | 4.5 g q8h |
| < 10 or PD | 3.375 g q12h | 4.5 g q12h |
| Hemodialysis (HD) |
3.375 g q12h On dialysis days, give one of the doses towards the end of HD |
4.5 g q12h On dialysis days, give one of the doses towards the end of HD |
| Continuous Renal Replacement Therapy (CRRT) | 3.375 g q6h | 4.5 g q6h |
| Sustained Low Efficiency Dialysis (SLED)5 |
3.375 g q12-8h* | 4.5 g q12-8h* |
*Dose will be dependent on severity of illness and duration/frequency of SLED dialysis sessions
Dosing
- Usual Dosage: Variable
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 15 to 30 mg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 25 to 35 mg/kg q24h. Max 2.5 g.
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: Usual dose 3 days per week
- ESRD (CrCl < 10 mL/min): Usual dose 3 days per week
- PD: Usual dose 3 days per week
- HD: Usual dose 3 days per week on HD days to be given after HD
- CRRT: Usual dosage
Dosing
- Usual Dosage: 50 to 75 mg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: 600 mg q24h
- No dosage adjustment for renal impairment or dialysis
Dosing
- Usual Dosage: Dose varies with indication
- CrCl 30 - 49 mL/min: Avoid
- CrCl 10 - 29 mL/min: Avoid
- ESRD (CrCl < 10 mL/min): Avoid
- PD: Avoid
- HD: Avoid
- CRRT: Avoid
Dosing
- Usual Dosage: 3.1 g q6h
- CrCl 30 - 49 mL/min: 3.1 g q6h
- CrCl 10 - 29 mL/min: 3.1 g q8h
- ESRD (CrCl < 10 mL/min): 3.1 g q12h
- PD: 3.1 g q12h
- HD: 3.1 g q12h
- On dialysis days, give one of the doses towards the end of HD
- CRRT: 3.1 g q6h
* Non-Formulary. Restricted to Infectious Diseases for Stenotrophomonas infections.
Dosing
- Usual Dosage: 100 mg load; then 50 mg q12h
- No dosage adjustment for renal impairment or dialysis
*Non-Formulary. Restricted to Infectious Diseases
Please refer to the guideline for aminoglycosides.
Dosing
- Usual Dosage: 100 mg q12h (monotherapy for uncomplicated UTI)
- CrCl 30 - 49 mL/min: Usual dosage
- CrCl 10 - 29 mL/min: 75% of the usual total dose per day
- ESRD (CrCl < 10 mL/min): 100 mg q24h
- PD: 100 mg q24h
- HD: 100 mg q24h
- CRRT: Usual dosage
Dosing
- Usual Dosage: 1 g q8 - 12h
- CrCl 30 - 49 mL/min: 1 g q12h.
- CrCl 10 - 29 mL/min: 500 mg q8h.
- ESRD (CrCl < 10 mL/min) or PD: 1 g q24h.
- Monitor for CNS toxicity.
- PD: 1 g q24h.
- Monitor for CNS toxicity.
- HD: 1 g q24h.
- On dialysis days, give daily dose after HD.
- Monitor for CNS toxicity.
- CRRT: Usually use IV acyclovir
Please refer to the Vancomycin Antimicrobial Guideline.
Dosing
- Usual Dosage: 6 mg/kg q12h x 2 doses; then 4 mg/kg q12h*
- CrCl 30 - 49 mL/min: Usual dosage*
- CrCl 10 - 29 mL/min: Usual dosage*
- ESRD (CrCl < 10 mL/min): Usual dosage*
- PD: Usual dosage*
- HD: Usual dosage*
- CRRT: Usual dosage*
* Tablets available in 50 mg and 200 mg strength. Round dose to the nearest 50 mg.
** Restricted to Infectious Diseases; also Hematology-Oncology (for prophylaxis in patients receiving AML-type chemotherapy)
Dosing
- Usual Dosage: 6 mg/kg q12h x 2 doses; then 4 mg/kg q12h
- CrCl 30 - 49 mL/min: Usual dosage (oral preferred – see below)
- CrCl 10 - 29 mL/min: Usual dosage (oral preferred – see below)
- ESRD (CrCl < 10 mL/min) or PD: Usual dosage (oral preferred – see below)
- PD: Usual dosage (oral preferred – see below)
- HD: Usual dosage (oral preferred – see below)
- CRRT: Usual Dosage*
NOTE: If CrCl < 50 mL/min, oral therapy is preferred since the IV product contains an ingredient that accumulates in renal insufficiency. If the oral route is not an option, weigh the benefits and potential risks when considering IV therapy.
* Restricted to Infectious Diseases; also Hematology-Oncology (for prophylaxis in patients receiving AML-type chemotherapy
